{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:54:16Z","timestamp":1790650456490,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T00:00:00Z","timestamp":1438041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/leu.2015.202","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T08:57:12Z","timestamp":1438073832000},"page":"94-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development"],"prefix":"10.1038","volume":"30","author":[{"given":"A M","family":"Roncero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"L\u00f3pez-Nieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Cobos-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Villa-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gonz\u00e1lez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"L\u00f3pez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Llamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ayuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Rodr\u00edguez-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Arriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Fern\u00e1ndez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fern\u00e1ndez-Piqueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"BFleu2015202_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","volume":"72","author":"L de Leval","year":"2009","unstructured":"de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P . Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol 2009; 72: 125\u2013143.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFleu2015202_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nri2304","volume":"8","author":"I Aifantis","year":"2008","unstructured":"Aifantis I, Raetz E, Buonamici S . Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008; 8: 380\u2013390.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2015202_CR3","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Van Vlierberghe","year":"2012","unstructured":"Van Vlierberghe P, Ferrando A . The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398\u20133406.","journal-title":"J Clin Invest"},{"key":"BFleu2015202_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2141.2009.08006.x","volume":"149","author":"B Burkhardt","year":"2010","unstructured":"Burkhardt B . Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? Br J Haematol 2010; 149: 653\u2013668.","journal-title":"Br J Haematol"},{"key":"BFleu2015202_CR5","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","volume":"121","author":"BR Bonn","year":"2013","unstructured":"Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F et al. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 2013; 121: 3153\u20133160.","journal-title":"Blood"},{"key":"BFleu2015202_CR6","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","volume":"178","author":"PJ Murray","year":"2007","unstructured":"Murray PJ . The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178: 2623\u20132629.","journal-title":"J Immunol"},{"key":"BFleu2015202_CR7","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2012.347","volume":"32","author":"W Vainchenker","year":"2013","unstructured":"Vainchenker W, Constantinescu SN . JAK\/STAT signaling in hematological malignancies. Oncogene 2013; 32: 2601\u20132613.","journal-title":"Oncogene"},{"key":"BFleu2015202_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20072182","volume":"205","author":"E Flex","year":"2008","unstructured":"Flex E, Petrangeli V, Stella L, Chiaretti S, Hornakova T, Knoops L et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008; 205: 751\u2013758.","journal-title":"J Exp Med"},{"key":"BFleu2015202_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2141.2009.07912.x","volume":"148","author":"V Asnafi","year":"2010","unstructured":"Asnafi V, Le Noir S, Lhermitte L, Gardin C, Legrand F, Vallantin X et al. JAK1 mutations are not frequent events in adult T-ALL: a GRAALL study. Br J Haematol 2010; 148: 178\u2013179.","journal-title":"Br J Haematol"},{"key":"BFleu2015202_CR10","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-07-4839","volume":"14","author":"EG Jeong","year":"2008","unstructured":"Jeong EG, Kim MS, Nam HK, Min CK, Lee S, Chung YJ et al. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res 2008; 14: 3716\u20133721.","journal-title":"Clin Cancer Res"},{"key":"BFleu2015202_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu2015202_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","volume":"278","author":"V Lacronique","year":"1997","unstructured":"Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 1997; 278: 1309\u20131312.","journal-title":"Science"},{"key":"BFleu2015202_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054\u20131061.","journal-title":"Lancet"},{"key":"BFleu2015202_CR14","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131790.","journal-title":"N Engl J Med"},{"key":"BFleu2015202_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144\u20131148.","journal-title":"Nature"},{"key":"BFleu2015202_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387\u2013397.","journal-title":"Cancer Cell"},{"key":"BFleu2015202_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0092-8674(95)90351-8","volume":"80","author":"U Klingmuller","year":"1995","unstructured":"Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF . Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80: 729\u2013738.","journal-title":"Cell"},{"key":"BFleu2015202_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura A, Naka T, Kubo M . SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7: 454\u2013465.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2015202_CR19","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","volume":"105","author":"I Melzner","year":"2005","unstructured":"Melzner I, Bucur AJ, Bruderlein S, Dorsch K, Hasel C, Barth TF et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 2005; 105: 2535\u20132542.","journal-title":"Blood"},{"key":"BFleu2015202_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3324\/haematol.2011.041921","volume":"96","author":"M Kleppe","year":"2011","unstructured":"Kleppe M, Tousseyn T, Geissinger E, Kalender Atak Z, Aerts S, Rosenwald A et al. Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma. Haematologica 2011; 96: 1723\u20131727.","journal-title":"Haematologica"},{"key":"BFleu2015202_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.leu.2404513","volume":"21","author":"E Jost","year":"2007","unstructured":"Jost E, do ON, Dahl E, Maintz CE, Jousten P, Habets L et al. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR\/ABL-negative myeloproliferative disorders. Leukemia 2007; 21: 505\u2013510.","journal-title":"Leukemia"},{"key":"BFleu2015202_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.immuni.2011.12.015","volume":"36","author":"JJ Babon","year":"2012","unstructured":"Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, Young SN et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 2012; 36: 239\u2013250.","journal-title":"Immunity"},{"key":"BFleu2015202_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.gastro.2006.04.025","volume":"131","author":"H Ogata","year":"2006","unstructured":"Ogata H, Kobayashi T, Chinen T, Takaki H, Sanada T, Minoda Y et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 2006; 131: 179\u2013193.","journal-title":"Gastroenterology"},{"key":"BFleu2015202_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature08448","volume":"461","author":"MA Dawson","year":"2009","unstructured":"Dawson MA, Bannister AJ, Gottgens B, Foster SD, Bartke T, Green AR et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009; 461: 819\u2013822.","journal-title":"Nature"},{"key":"BFleu2015202_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75\u201387.","journal-title":"Cancer Cell"},{"key":"BFleu2015202_CR26","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood-2003-07-2577","volume":"103","author":"AA Ferrando","year":"2004","unstructured":"Ferrando AA, Herblot S, Palomero T, Hansen M, Hoang T, Fox EA et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood 2004; 103: 1909\u20131911.","journal-title":"Blood"},{"key":"BFleu2015202_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1182378","volume":"327","author":"MP McCormack","year":"2010","unstructured":"McCormack MP, Young LF, Vasudevan S, de Graaf CA, Codrington R, Rabbitts TH et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 2010; 327: 879\u2013883.","journal-title":"Science"},{"key":"BFleu2015202_CR28","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1182\/blood-2010-09-309831","volume":"117","author":"LM Treanor","year":"2011","unstructured":"Treanor LM, Volanakis EJ, Zhou S, Lu T, Sherr CJ, Sorrentino BP . Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Blood 2011; 117: 5453\u20135462.","journal-title":"Blood"},{"key":"BFleu2015202_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/PAS.0b013e318213e90e","volume":"35","author":"I Oschlies","year":"2011","unstructured":"Oschlies I, Burkhardt B, Chassagne-Clement C, d'Amore ES, Hansson U, Hebeda K et al. Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol 2011; 35: 836\u2013844.","journal-title":"Am J Surg Pathol"},{"key":"BFleu2015202_CR30","first-page":"176","volume-title":"WHO Classification of Tumours, Volume 2","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al WHO Classification of Tumours, Volume 2. International Agency for Research on Cancer (IARC) World Health Organization (WHO): Lyon, France, 2008; 2: 176\u2013178."},{"key":"BFleu2015202_CR31","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V85.12.3662.bloodjournal85123662","volume":"85","author":"SP Romana","year":"1995","unstructured":"Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662\u20133670.","journal-title":"Blood"},{"key":"BFleu2015202_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3324\/haematol.2008.002352","volume":"94","author":"J Elliott","year":"2009","unstructured":"Elliott J, Suessmuth Y, Scott LM, Nahlik K, McMullin MF, Constantinescu SN et al. SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases. Haematologica 2009; 94: 576\u2013580.","journal-title":"Haematologica"},{"key":"BFleu2015202_CR33","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1073\/pnas.170291697","volume":"97","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier L, Van Roost E, Colau D, Renauld JC . Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144\u201310149.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015202_CR34","first-page":"29","volume":"28","author":"H Yoshikawa","year":"2001","unstructured":"Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE et al. SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001; 28: 29\u201335.","journal-title":"Nat Genet"},{"key":"BFleu2015202_CR35","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1038\/sj.onc.1208818","volume":"24","author":"A Weber","year":"2005","unstructured":"Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 2005; 24: 6699\u20136708.","journal-title":"Oncogene"},{"key":"BFleu2015202_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2353\/ajpath.2010.090236","volume":"176","author":"H Sato","year":"2010","unstructured":"Sato H, Oka T, Shinnou Y, Kondo T, Washio K, Takano M et al. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia\/lymphoma. Am J Pathol 2010; 176: 402\u2013415.","journal-title":"Am J Pathol"},{"key":"BFleu2015202_CR37","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2011; 118: 3080\u20133087.","journal-title":"Blood"},{"key":"BFleu2015202_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1073\/pnas.0911726107","volume":"107","author":"A Yoda","year":"2010","unstructured":"Yoda A, Yoda Y, Chiaretti S, Bar-Natan M, Mani K, Rodig SJ et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2010; 107: 252\u2013257.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015202_CR39","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","volume":"372","author":"D Bercovich","year":"2008","unstructured":"Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 2008; 372: 1484\u20131492.","journal-title":"Lancet"},{"key":"BFleu2015202_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1365-2141.2008.07552.x","volume":"144","author":"A Gaikwad","year":"2009","unstructured":"Gaikwad A, Rye CL, Devidas M, Heerema NA, Carroll AJ, Izraeli S et al. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia. Br J Haematol 2009; 144: 930\u2013932.","journal-title":"Br J Haematol"},{"key":"BFleu2015202_CR41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1182\/blood-2008-08-170928","volume":"113","author":"L Kearney","year":"2009","unstructured":"Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M et al. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood 2009; 113: 646\u2013648.","journal-title":"Blood"},{"key":"BFleu2015202_CR42","doi-asserted-by":"publisher","first-page":"e11157","DOI":"10.1371\/journal.pone.0011157","volume":"5","author":"A Dusa","year":"2010","unstructured":"Dusa A, Mouton C, Pecquet C, Herman M, Constantinescu SN . JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors. PLoS One 2010; 5: e11157.","journal-title":"PLoS One"},{"key":"BFleu2015202_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nri818","volume":"2","author":"WS Alexander","year":"2002","unstructured":"Alexander WS . Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2: 410\u2013416.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2015202_CR44","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1042\/BST20130077","volume":"41","author":"NJ Kershaw","year":"2013","unstructured":"Kershaw NJ, Murphy JM, Lucet IS, Nicola NA, Babon JJ . Regulation of Janus kinases by SOCS proteins. Biochem Soc Trans 2013; 41: 1042\u20131047.","journal-title":"Biochem Soc Trans"},{"key":"BFleu2015202_CR45","doi-asserted-by":"publisher","first-page":"14133","DOI":"10.1073\/pnas.2232790100","volume":"100","author":"B He","year":"2003","unstructured":"He B, You L, Uematsu K, Zang K, Xu Z, Lee AY et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci USA 2003; 100: 14133\u201314138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015202_CR46","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1038\/sj.onc.1207787","volume":"23","author":"KD Sutherland","year":"2004","unstructured":"Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W et al. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 2004; 23: 7726\u20137733.","journal-title":"Oncogene"},{"key":"BFleu2015202_CR47","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3324\/haematol.13043","volume":"93","author":"N Fourouclas","year":"2008","unstructured":"Fourouclas N, Li J, Gilby DC, Campbell PJ, Beer PA, Boyd EM et al. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders. Haematologica 2008; 93: 1635\u20131644.","journal-title":"Haematologica"},{"key":"BFleu2015202_CR48","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","volume":"109","author":"MB Hookham","year":"2007","unstructured":"Hookham MB, Elliott J, Suessmuth Y, Staerk J, Ward AC, Vainchenker W et al. The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood 2007; 109: 4924\u20134929.","journal-title":"Blood"},{"key":"BFleu2015202_CR49","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1582-4934.2010.01018.x","volume":"14","author":"C Haan","year":"2010","unstructured":"Haan C, Behrmann I, Haan S . Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases. J Cell Mol Med 2010; 14: 504\u2013527.","journal-title":"J Cell Mol Med"},{"key":"BFleu2015202_CR50","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1182\/blood.V93.12.4354","volume":"93","author":"JM Ho","year":"1999","unstructured":"Ho JM, Beattie BK, Squire JA, Frank DA, Barber DL . Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. Blood 1999; 93: 4354\u20134364.","journal-title":"Blood"},{"key":"BFleu2015202_CR51","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1093\/emboj\/17.18.5321","volume":"17","author":"J Schwaller","year":"1998","unstructured":"Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL\/JAK2 fusion genes. EMBO J 1998; 17: 5321\u20135333.","journal-title":"EMBO J"},{"key":"BFleu2015202_CR52","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nsmb.2099","volume":"18","author":"D Ungureanu","year":"2011","unstructured":"Ungureanu D, Wu J, Pekkala T, Niranjan Y, Young C, Jensen ON et al. The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling. Nat Struct Mol Biol 2011; 18: 971\u2013976.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu2015202_CR53","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/MCB.24.11.4955-4967.2004","volume":"24","author":"LS Argetsinger","year":"2004","unstructured":"Argetsinger LS, Kouadio JL, Steen H, Stensballe A, Jensen ON, Carter-Su C . Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol Cell Biol 2004; 24: 4955\u20134967.","journal-title":"Mol Cell Biol"},{"key":"BFleu2015202_CR54","first-page":"263","volume":"13","author":"G Baltayiannis","year":"2008","unstructured":"Baltayiannis G, Baltayiannis N, Tsianos EV . Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver. J BUON 2008; 13: 263\u2013265.","journal-title":"J BUON"},{"key":"BFleu2015202_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2407-10-178","volume":"10","author":"W Sasi","year":"2010","unstructured":"Sasi W, Jiang WG, Sharma A, Mokbel K . Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer. BMC Cancer 2010; 10: 178.","journal-title":"BMC Cancer"},{"key":"BFleu2015202_CR56","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/sj.onc.1208032","volume":"24","author":"J Reddy","year":"2005","unstructured":"Reddy J, Shivapurkar N, Takahashi T, Parikh G, Stastny V, Echebiri C et al. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene 2005; 24: 732\u2013736.","journal-title":"Oncogene"},{"key":"BFleu2015202_CR57","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/1078-0432.CCR-06-2303","volume":"13","author":"H Zhou","year":"2007","unstructured":"Zhou H, Miki R, Eeva M, Fike FM, Seligson D, Yang L et al. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Clin Cancer Res 2007; 13: 2344\u20132353.","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2015202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2015202","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2015202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T06:51:11Z","timestamp":1718002271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFleu2015202"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.202","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]},"assertion":[{"value":"10 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}